Skip Navigation

skip navigationNIDDK Home
NIDDK Reference Collection
Diet   Exercise   Health  
Home Page
-  

FAQ

Detailed Search

- -
NIDDK INFORMATION SERVICES
- -

Diabetes

Digestive Diseases

Endocrine and Metabolic Diseases

Hematologic Diseases

Kidney and Urologic Diseases

Weight-control Information Network

-
NIDDK EDUCATION
PROGRAMS

- -

National Diabetes Education Program

National Kidney Disease Education Program

-
- - -
NIDDK Home
-
Contact Us
-
New Search
-
Topic: hematologic diseases (he)
Title: Antiphospholipid Syndrome.
Author: Rand, J.H.
Source: IN: Hematology 2007. Washington, DC: American Society of Hematology. 2007. pp.136-142.
Availability: Available from American Society of Hematology. 1900 M Street NW, Suite 200, Washington, DC 20036. Email: ASH@hematology.org. Website: www.asheducationbook.org. Price: Available free on website.
Abstract: This chapter, from the annual Hematology 2007, describes the antiphospholipid syndrome (APS), an autoimmune thrombophilic condition that is marked by the presence of antibodies that recognize phospholipid-binding proteins. Patients with APS tend to present with vascular thrombosis and pregnancy complications, especially recurrent, spontaneous miscarriages. The author focuses on updated diagnostic and therapeutic approaches to this disorder. The author recommends that testing for antiphospholipid (aPL) antibodies should usually be restricted to patients who have had thrombosis, embolism, or pregnancy complications that may be attributable to APS, and to patients with systemic lupus erythematosus (SLE) even if they have not had these manifestations. An initial venous thromboembolism (VTE) in patients with confirmed APS should be treated with warfarin. Recurrence of VTE in the face of standard treatment should be treated with higher intensity coagulation or in selected situations with a form of low-molecular-weight heparin (LMWH). For pregnant patients with VTE, the author recommends treatment with prophylactic dose heparin plus low-dose aspirin (81 milligrams daily), with modification of administration for delivery, followed by resumption of prophylactic anticoagulation. 2 figures. 3 tables. 41 references.

Format: Monograph/Book
Language: English.
Major Keywords: Hematologic Diseases. Thrombosis. Diagnosis. Etiology. Diagnostic Tests. Anticoagulants. Patient Care Management.
Minor Keywords: Drug Therapy. Administration and Dosage. Drug Effects. Patient Selection. Risk Factors. Pregnancy. Complications.
Publication Number: HEBK10215
Printer-Friendly Version | Return to Search Results
<-- previous record | next record -->

View NIDDK Publications | NIDDK Health Information | Contact Us

The NIDDK Reference Collection is a service of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
NIDDK Clearinghouses Publications Catalog
5 Information Way
Bethesda, MD 20892–3568
Phone: 1–800–860–8747
TTY: 1–866–569–1162
Fax: 703–738–4929
Email: catalog@niddk.nih.gov

Privacy | Disclaimers | Accessibility | Public Use of Materials
H H S logo - link to U. S. Department of Health and Human Services NIH logo - link to the National Institute of Health NIDDK logo - link to the National Institute of Diabetes and Digestive and Kidney Diseases